On Friday, November 13, 2026, Jim Cramer's Charitable Trust executed three significant trades to rebalance its consumer exposure. The portfolio manager sold 475 shares of TJX Companies at an approximate price of $135 per share. This transaction reduced the trust's holding to 500 shares and lowered the stock's weighting within the portfolio to approximately 1.8 percent, down from the previous 3.4 percent.
The decision to trim the TJX position followed a downgrade by the firm Gordon Haskett, which moved the stock to a hold rating with a price target of $130. Analysts at Haskett cited ongoing competitive pressures from Ross Stores and persistent execution challenges within Marmaxx, which is TJX's largest segment encompassing the TJ Maxx and Marshalls brands. These factors contributed to underwhelming results in the second quarter.
Cramer's trust had previously accumulated TJX shares in September when the stock price declined from $140 to the $120 range. At that time, the investment team believed the market was overreacting to what appeared to be a rare operational hiccup at a well-managed company. Most of those shares were sold in mid-October as the stock recovered to around $145, with the team noting that internal issues seemed to have been resolved.
However, Haskett's recent analysis indicates that customer traffic trends at co-located Ross Stores and Marmaxx locations continue to favor Ross. The report also suggests that the market share gains Marmaxx had secured from Target in recent years may be stagnating due to Target's own improvement initiatives. While this represents a single analyst perspective, the trust aims to avoid holding excessive exposure to TJX ahead of its earnings report scheduled for next Wednesday, particularly if Marmaxx delivers another disappointing quarter.
From the sale of TJX shares, the trust realized an average gain of roughly 113 percent on stock purchased in August 2022 and March 2023. The capital generated from this sale is being reallocated into two other consumer companies: Kimberly-Clark and Constellation Brands.
The trust purchased 300 shares of Kimberly-Clark at approximately $108 per share. This move increased the holding to 900 shares and raised the stock's portfolio weighting to about 2.5 percent from 1.65 percent. The investment thesis is supported by the recent closure of the Kenvue deal, which the team believes has not been fully appreciated by the market in terms of Kimberly-Clark's ability to revitalize its consumer health brand. The company recently reported quarterly results that exceeded expectations.
Simultaneously, the trust bought 220 shares of Constellation Brands at approximately $145 per share. This addition brings the total holding to 490 shares and increases the weighting to 1.8 percent from 1 percent. The initial position in Constellation Brands was established earlier this week, driven by improvements in beer sales and the potential positive impact of easing immigration policies following the Democrats' midterm election victories.
Subscribers to the CNBC Investing Club with Jim Cramer receive advance trade alerts. Cramer typically waits 45 minutes after sending an alert before executing trades in his charitable trust's portfolio. If he has discussed a specific stock on CNBC television, he waits 72 hours after issuing the alert before completing the transaction.
These adjustments reflect a strategic shift within the consumer sector, prioritizing companies with perceived undervalued turnaround potential or favorable macroeconomic tailwinds over those facing intensifying competitive threats.
The portfolio changes underscore the importance of monitoring analyst sentiment and competitive dynamics, particularly for companies operating in the off-price retail and consumer health spaces where market share shifts can significantly impact long-term valuation.
